Cancer- and treatment-related anemia

Clinical Practice Guidelines in Oncology

George M. Rodgers, David Cella, Asher Chanan-Khan, Carolyn Chesney, Charles Cleeland, Peter Felix Coccia, George D. Demetri, Benjamin Djulbegovic, Jennifer L. Garst, Margaret Gore, Eric H. Kraut, Weei Chin Lin, Michael Millenson, Victoria Mock, Denise Reinke, Joseph Rosenthal, Paul Sabbatini

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy.

Original languageEnglish (US)
Pages (from-to)772-789
Number of pages18
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume3
Issue number6
StatePublished - Nov 1 2005

Fingerprint

Second Primary Neoplasms
Practice Guidelines
Anemia
Guidelines
Drug Therapy
Proxy
Chronic Disease
Quality of Life
Neoplasms

Keywords

  • Anemia
  • Chemotherapy
  • Darbapoetin
  • Epoetin
  • Erythropoietin
  • Ferric gluconate
  • Heme iron polypeptide
  • Hemoglobin
  • Iron dextran
  • Iron sucrose
  • NCCN Clinical Practice Guidelines in Oncology
  • Quality of life
  • Serum ferritin

ASJC Scopus subject areas

  • Oncology

Cite this

Rodgers, G. M., Cella, D., Chanan-Khan, A., Chesney, C., Cleeland, C., Coccia, P. F., ... Sabbatini, P. (2005). Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network, 3(6), 772-789.

Cancer- and treatment-related anemia : Clinical Practice Guidelines in Oncology. / Rodgers, George M.; Cella, David; Chanan-Khan, Asher; Chesney, Carolyn; Cleeland, Charles; Coccia, Peter Felix; Demetri, George D.; Djulbegovic, Benjamin; Garst, Jennifer L.; Gore, Margaret; Kraut, Eric H.; Lin, Weei Chin; Millenson, Michael; Mock, Victoria; Reinke, Denise; Rosenthal, Joseph; Sabbatini, Paul.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 3, No. 6, 01.11.2005, p. 772-789.

Research output: Contribution to journalReview article

Rodgers, GM, Cella, D, Chanan-Khan, A, Chesney, C, Cleeland, C, Coccia, PF, Demetri, GD, Djulbegovic, B, Garst, JL, Gore, M, Kraut, EH, Lin, WC, Millenson, M, Mock, V, Reinke, D, Rosenthal, J & Sabbatini, P 2005, 'Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 3, no. 6, pp. 772-789.
Rodgers GM, Cella D, Chanan-Khan A, Chesney C, Cleeland C, Coccia PF et al. Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2005 Nov 1;3(6):772-789.
Rodgers, George M. ; Cella, David ; Chanan-Khan, Asher ; Chesney, Carolyn ; Cleeland, Charles ; Coccia, Peter Felix ; Demetri, George D. ; Djulbegovic, Benjamin ; Garst, Jennifer L. ; Gore, Margaret ; Kraut, Eric H. ; Lin, Weei Chin ; Millenson, Michael ; Mock, Victoria ; Reinke, Denise ; Rosenthal, Joseph ; Sabbatini, Paul. / Cancer- and treatment-related anemia : Clinical Practice Guidelines in Oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2005 ; Vol. 3, No. 6. pp. 772-789.
@article{f28f244f259e413daae151b6863e1798,
title = "Cancer- and treatment-related anemia: Clinical Practice Guidelines in Oncology",
abstract = "Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy.",
keywords = "Anemia, Chemotherapy, Darbapoetin, Epoetin, Erythropoietin, Ferric gluconate, Heme iron polypeptide, Hemoglobin, Iron dextran, Iron sucrose, NCCN Clinical Practice Guidelines in Oncology, Quality of life, Serum ferritin",
author = "Rodgers, {George M.} and David Cella and Asher Chanan-Khan and Carolyn Chesney and Charles Cleeland and Coccia, {Peter Felix} and Demetri, {George D.} and Benjamin Djulbegovic and Garst, {Jennifer L.} and Margaret Gore and Kraut, {Eric H.} and Lin, {Weei Chin} and Michael Millenson and Victoria Mock and Denise Reinke and Joseph Rosenthal and Paul Sabbatini",
year = "2005",
month = "11",
day = "1",
language = "English (US)",
volume = "3",
pages = "772--789",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "6",

}

TY - JOUR

T1 - Cancer- and treatment-related anemia

T2 - Clinical Practice Guidelines in Oncology

AU - Rodgers, George M.

AU - Cella, David

AU - Chanan-Khan, Asher

AU - Chesney, Carolyn

AU - Cleeland, Charles

AU - Coccia, Peter Felix

AU - Demetri, George D.

AU - Djulbegovic, Benjamin

AU - Garst, Jennifer L.

AU - Gore, Margaret

AU - Kraut, Eric H.

AU - Lin, Weei Chin

AU - Millenson, Michael

AU - Mock, Victoria

AU - Reinke, Denise

AU - Rosenthal, Joseph

AU - Sabbatini, Paul

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy.

AB - Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy.

KW - Anemia

KW - Chemotherapy

KW - Darbapoetin

KW - Epoetin

KW - Erythropoietin

KW - Ferric gluconate

KW - Heme iron polypeptide

KW - Hemoglobin

KW - Iron dextran

KW - Iron sucrose

KW - NCCN Clinical Practice Guidelines in Oncology

KW - Quality of life

KW - Serum ferritin

UR - http://www.scopus.com/inward/record.url?scp=33644824195&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644824195&partnerID=8YFLogxK

M3 - Review article

VL - 3

SP - 772

EP - 789

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 6

ER -